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Abstract. 
 
Neurofascin is a member of the L1 subgroup 
of the Ig superfamily that promotes axon outgrowth by 
interactions with neuronal NgCAM-related cell adhesion 
molecule (NrCAM). We used a combination of cellular 
binding assays and neurite outgrowth experiments to 
investigate mechanisms that might modulate the inter-
actions of neurofascin. In addition to NrCAM, we here 
demonstrate that neurofascin also binds to the extracel-
lular matrix glycoprotein tenascin-R (TN-R) and to the 
Ig superfamily members axonin-1 and F11.
Isoforms of neurofascin that are generated by alter-
native splicing show different preferences in ligand 
binding. While interactions of neurofascin with F11 are 
only slightly modulated, binding to axonin-1 and TN-R 
is strongly regulated by alternatively spliced stretches 
 
located in the NH
 
2
 
-terminal half, and by the proline-
alanine-threonine-rich segment.
In vitro neurite outgrowth and cell attachment assays 
on a neurofascin-Fc substrate reveal a shift of cellular 
receptor usage from NrCAM to axonin-1, F11, and at 
least one additional protein in the presence of TN-R, 
presumably due to competition of the neurofascin–
NrCAM interaction. Thereby, F11 binds to TN-R of 
the neurofascin/TN-R complex, but not to neurofascin, 
whereas axonin-1 is not able to bind directly to the neu-
rofascin/TN-R complex as shown by competition bind-
ing assays.
In conclusion, these investigations indicate that the 
molecular interactions of neurofascin are regulated at 
different levels, including alternative splicing and by 
the presence of interacting proteins.
Key words: neurofascin • cell adhesion • axonal out-
growth • Ig superfamily • tenascin-R
 
A
 
xonal
 
 growth and pathfinding by permissive cues in
the local environment of the growth cone may in-
volve the function of L1-like proteins that form a
subgroup within the Ig superfamily comprising L1/neuron-
glia cell adhesion molecule (NgCAM),
 
1
 
 neurofascin, Ng-
CAM-related cell adhesion molecule (NrCAM), and CHL1
in vertebrates (Cunningham, 1995; Hortsch, 1996; Brüm-
mendorf et al., 1998).They are concentrated in axon tracts
of the developing and adult nervous system in a partial
overlapping distribution. The L1-like proteins share a
common overall domain organization and related amino
acid sequences (Brümmendorf and Rathjen, 1996). They
are composed of six NH
 
2
 
-terminal Ig-like domains fol-
lowed by five fibronectin type III (FNIII)-like repeats, a
transmembrane domain, and a highly conserved cytoplas-
mic domain that confers cytoskeletal associations via
ankyrin (Davis and Bennett, 1994; Hassel et al., 1997;
Davis et al., 1993; Brümmendorf and Rathjen, 1995). The
importance of the L1-related proteins on the development
of the nervous system is exemplified by the observation
that mutations in the human L1 gene cause the related
mental retardation diseases X-linked hydrocephalus, MASA
syndrome (mental retardation, aphasia, shuffling gait, and
adducted thumbs), and spastic paraplegia type I (Wong et
al., 1995; Brümmendorf et al., 1998; Fransen et al., 1997;
Kenwrick et al., 1996). Consistently, the embryonic devel-
opment of the corticospinal tract is compromised in L1-
deficient mice, and depending on the genetic background,
the lateral ventricles of the brain are enlarged (Dahme et
al., 1997; Cohen et al., 1997).
Within the L1 subgroup, neurofascin is unique as it con-
tains a proline-alanine-threonine-rich segment (termed
PAT domain) between the fourth and fifth FNIII-like re-
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peats that may be the target of O-glycosylation (Volkmer
et al., 1992). cDNA cloning and genomic analysis of neuro-
fascin indicated that at least 50 different isoforms are gen-
erated by alternate usage of nine alternatively spliced ex-
ons spread over the complete gene (Hassel et al., 1997).
There are three alternatively spliced sequences comprising
complete domains, the third as well as the fifth FNIII-like
repeat and the PAT domain, and four short stretches of 4–15
amino acid residues in length (see Fig. 2 
 
D
 
). They are lo-
cated at the NH
 
2
 
 terminus between the second and third
Ig-like domain at the junction between the Ig- and the
FNIII-like domains and in the cytoplasmic segment. Iso-
forms that contain either the third or the fifth FNIII-like
repeat are selectively localized either on unmyelinated ax-
ons or on the nodes of Ranvier in the peripheral nervous
system, respectively (Davis et al., 1996).
We extended antibody perturbation assays delineating a
crucial role of neurofascin in axon fasciculation by studies
of neurite outgrowth on recombinant neurofascin-Fc sub-
strates, showing that the interaction with cellular NrCAM
promotes neurite outgrowth of tectal cells (Volkmer et al.,
1996; Rathjen et al., 1987
 
a
 
). This neurofascin–NrCAM in-
teraction, however, appears not to be reciprocal for neu-
rite outgrowth since tectal neurons use the F11 protein
and not neurofascin to extend neurites on immobilized Nr-
CAM, suggesting the ability of a neuron to regulate molec-
ular interactions of Ig-like proteins (Volkmer et al., 1996).
Analysis of the binding characteristics of neurofascin dele-
tion mutants indicated that the Ig-like domains of neuro-
fascin are sufficient for interaction with NrCAM. To some
extent, interactions with NrCAM are modulated by using
specific amino acid stretches located in the NH
 
2
 
-terminal
half of the polypeptide, and by the PAT domain (Volkmer
et al., 1996).
Up to now a variety of molecular interactions have been
described for the L1-like proteins NgCAM, NrCAM, and
for L1 itself (Brümmendorf and Rathjen, 1996). In addi-
tion to homophilic binding activities, NgCAM as well as
NrCAM interact both with the glycosyl-phosphatidylinosi-
tol (GPI)-linked neural Ig superfamily (IgSF) members
F11 and axonin-1 (Suter et al., 1995; Kuhn et al., 1991;
Brümmendorf et al., 1993; Morales et al., 1993). The inter-
action between F11 and NrCAM induces neurite out-
growth of tectal cells (Volkmer et al., 1996; Morales et
al., 1993) and retinal cells (Treubert and Brümmendorf,
1998), and the NrCAM/axonin-1 interaction contributes to
the guidance of commissural axons to the floor plate of the
spinal cord, and is implicated in neuron–glia interactions
(Suter et al., 1995; Stoeckli et al., 1997; Stoeckli and Land-
messer, 1995). NgCAM and F11 also provide linkages to
the extracellular matrix (ECM) by interactions with lami-
nin-1, phosphacan, and neurocan, and with tenascin-R
(TN-R) and tenascin-C (TN-C; Milev et al., 1996; Grumet
et al., 1993; Zisch et al., 1992; Nörenberg et al., 1995;
Rathjen et al., 1991).
In contrast to many extracellular interactions that have
been described for L1/NgCAM and NrCAM, for neurofas-
cin only the neurite outgrowth–promoting interaction with
NrCAM has been characterized so far (Volkmer et al.,
1996). To further characterize the molecular function of
neurofascin, we were therefore interested in defining new
binding partners of neurofascin using a transfection-based
 
binding assay. We observed that the IgSF members F11
and axonin-1, and the ECM glycoprotein TN-R specifi-
cally interacted with neurofascin. We then asked at which
levels the molecular interactions of neurofascin can be
regulated that finally might contribute to axonal exten-
sion. The analysis of the binding of different neurofascin
isoforms to axonin-1, F11, and TN-R indicates that alter-
native splicing is one regulatory element to modulate the
activities of neurofascin. Cell adhesion and neurite out-
growth assays then demonstrated that binding of TN-R to
neurofascin induces a shift in receptor usage of tectal cells
to adhere and extend neurites, suggesting that the molecu-
lar composition of these interacting proteins appears to be
important for neurite outgrowth of tectal cells. 
 
Materials and Methods
 
Cloning Procedures and Purification of Neurofascin-Fc
 
Construction of neurofascin isoforms NF4, 6, 15, 16, 17, 22, 23, and 24 as
well as the deletion mutants NF13 (without Ig-like domains) and NF21
(without FNIII-like repeats) for expression in COS7 cells are detailed in
Volkmer et al. (1996). For construction of neurofascin expression plas-
mids pNF32
 
®
 
pNF38, either pNF6, pNF22, or pNF23 were digested by re-
striction endonuclease SmaI which cleaves within the first Ig-like domain
as well as within the first FNIII-like repeat, removing all Ig-like domains.
This region was then replaced by the Ig-like domains of pNF6, pNF15,
pNF23, or pNF24 to obtain permutations of the three small alternatively
spliced exons in the context of either a 3rd FNIII
 
1
 
/PAT
 
2
 
 or a 3rd FNIII
 
2
 
/
PAT
 
1
 
 construct (for a scheme of the isoforms see Fig. 2 
 
D
 
). An expression
plasmid coding for FcNF15 was generated by fusing the extracellular part
of NF15 to the Fc portion of human IgG1 (Simmons, 1993). Generation
and isolation of the neurofascin-Fc fusion protein (FcNF15) and of the Fc
portion of human IgG1 (DiFc) alone by Protein A affinity chromatogra-
phy was done essentially as described previously (Volkmer et al., 1996).
 
Immunoaffinity Purification of F11, Axonin-1, 
NgCAM, NrCAM, Neural Cell Adhedsion Molecule 
(NCAM), Neurofascin, TN-R and TN-C,
and Antibodies
 
F11, axonin-1, NgCAM, NrCAM, NCAM, neurofascin, TN-R, or TN-C
were purified from adult chicken brains by immunoaffinity chromatogra-
phy as described previously (Volkmer et al., 1996). Different TN-R
charges reveal a certain degree of variability to increase the relative cell
adherence to immobilized neurofascin-Fc. Isolation of monoclonal anti-
bodies, generation of Fab fragments of polyclonal antibodies to the pro-
teins listed above, and generation of bacterial fusion proteins containing
TN-R domains and polyclonal antibodies to these domains are detailed
elsewhere (Nörenberg et al., 1995; Nörenberg et al., 1992; Brümmendorf
et al., 1989; Wolff et al., 1987; Rathjen et al., 1987
 
a
 
; Rathjen et al., 1987
 
b
 
).
An mAb to axonin-1, kindly provided by P. Sonderegger (University of
Zürich), was used to purify axonin-1 from phosphatidylinositol-specific
phospholipase C
 
 
 
extracts of chicken brains (Rader et al., 1996). Polyclonal
antibodies to axonin-1 were generated by immunizing rabbits at 2-wk in-
tervals in Freund’s adjuvans.
 
Microsphere Binding Assay and Transfection
of COS7 Cells
 
Immunoaffinity-purified F11, axonin-1, NgCAM, NCAM, TN-R, or TN-C
were conjugated to red fluorescent microspheres 0.5 
 
m
 
m in diameter ac-
cording to the manufacturer’s protocol (Bioclean; Duke Scientific Corp.,
Palo Alto, CA), and residual binding sites were blocked by BSA. COS7
cells were transiently transfected with neurofascin-encoding plasmids as
detailed previously (Volkmer et al., 1996). At day 1 after transfection,
cells were transferred to collagen-coated 8-well chamber slides (Nunc,
Roskilde, Denmark), grown overnight, and then incubated at 37
 
8
 
C with
150 
 
m
 
l DMEM/10%FCS containing 1 
 
m
 
l of microsphere suspension. In an-
tibody inhibition experiments, Fab fragments of polyclonal antibodies to
neurofascin, TN-R, F11, or axonin-1 were added at a concentration of 200 
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m
 
g/ml. After 1 h of incubation, cells were washed, fixed in 4% formalde-
hyde/PBS, and stained for neurofascin expression by indirect immunoflu-
orescence using an antibody to neurofascin that does not interfere with
binding. For the quantification of microsphere binding and of neurofascin
expression on single cells, fluorescence levels were measured with a con-
focal microscope (MRC1024; Bio-Rad Laboratories, Hercules, CA). Im-
ages were analyzed for red fluorescence, indicating microspheres binding
to the cell and green fluorescence for neurofascin staining. Digital images
were analyzed using the public domain program NIH IMAGE (developed
at the United States National Institutes of Health and available on the in-
ternet at http://rsb.info.nih.gov/nih-image/). The procedure in general con-
forms with previously published methods (Volkmer et al., 1996). Individ-
ual neurofascin-expressing cells were outlined using a mouse cursor, and
the mean fluorescence intensity of each cell was determined as a measure
for the level of neurofascin expression. Microsphere binding was quanti-
fied by calculating the mean fluorescence intensity in the red channel
within the same outlined area of individual cells. Microsphere binding to
an individual cell was normalized with respect to the level of neurofascin
expression of the same cell, and background values measured over single
cells that did not bind microspheres were subtracted. About 20 cells per
experiment were measured. For competition assays, neurofascin-express-
ing COS7 cells were preincubated for 15 min with soluble TN-C or TN-R
at a concentration of 150 
 
m
 
g/ml before adding bioclean beads coated with
NrCAM, F11, or axonin-1.
 
Analysis of Cell Attachment and Neurite Outgrowth of 
Tectal Cells
 
For analyzing neurite extension, 100 
 
m
 
l of FcNF15, collagen, BSA, or the
Fc portion of human IgG1 (DiFc) were immobilized at a concentration of
10 
 
m
 
g/ml or of F11 at a concentration of 100 
 
m
 
g/ml per cm
 
2
 
 culture dish
(Petriperm; Bachhofer GmbH, Reutlingen, Germany). Residual binding
sites were blocked by washing and incubating with DMEM/10% FCS.
10,000 chick embryonic day 6 tectal cells per cm
 
2
 
 delineated by a silicon
fitting were plated in a volume of 100 
 
m
 
l DMEM/10%FCS and incubated
for 22 h. TN-R or TN-C was applied at a final concentration of 10 or 50
 
m
 
g/ml during the cultivation period. The different concentrations used
gave qualitatively the same results; however, the percentage of adhering
cells increased in the presence of the higher TN-R concentration (Fig. 3, 
 
A
 
and 
 
C
 
). Seven independent experiments were performed, two of these
with 50 
 
m
 
g/ml of TN-R. In cases of preincubation with TN-R, immobilized
neurofascin-Fc was incubated with TN-R at a concentration of 10 
 
m
 
g/ml
after blocking for 1 h. Unbound TN-R was removed by extensive washing
with DMEM/FCS before adding cells. Soluble axonin-1 or F11 was used at
20 
 
m
 
g/ml. Fab fragments of polyclonal antibodies to the different cell sur-
face proteins were added at a final concentration of 100 
 
m
 
g/ml, and mono-
clonal antibodies were added at a final concentration of 10 
 
m
 
g/ml of cul-
ture medium. After a 22-h cultivation, cells were fixed and stained by
indirect immunofluorescence using mAb A2B5 followed by Cy3-conju-
gated rabbit anti–mouse as secondary antibody (Dianova, Hamburg, Ger-
many). The cultures were analyzed using the GENIAS imaging software
to measure the number of attached cells and the length of neurites (Image
works, Teltow, Germany).
 
Immunoprecipitations
 
Immunoprecipitations of detergent extracts (0.5% octylglucoside and 1%
Triton X-100 in PBS supplemented with protease inhibitors) of chick reti-
nae of embryonic day 11/12 were performed with mAbs to neurofascin,
axonin-1, or F11 as detailed (Volkmer et al., 1996). Immunocomplexes
were precipitated with an mAb (HB58) directed to mouse 
 
k 
 
light chain
conjugated to CNBr-activated Sepharose (Pharmacia Biotech Sverige,
Uppsala, Sweden) followed by several washing steps using the solubiliza-
tion buffer. Immunoprecipitates were analyzed in 8% SDS-PAGE fol-
lowed by Western blotting with mAbs to neurofascin, NgCAM, axonin-1,
F11, or NCAM as primary antibodies, and alkaline phosphatase–conju-
gated anti-mouse polyclonal antibodies as secondary antibodies.
 
Results
 
F11, Axonin-1, and TN-R Bind to Neurofascin
 
An interesting feature of several axonal members of the
L1- and F11-subgroups of the IgSF is their complex bind-
ing pattern with other surface-associated proteins or ECM
glycoproteins (Brümmendorf and Rathjen, 1996). As
neurofascin-mediated neurite extension and fasciculation
might be modulated by distinct molecular interactions, we
are interested in defining novel binding partners of this
protein. As a first step we therefore analyzed whether neu-
rofascin also binds to the axon-associated IgSF members
NCAM, NgCAM, F11, axonin-1, or the ECM glycopro-
teins TN-C or TN-R. To this end, binding of protein-
coated fluorescent microspheres to COS7 cells that ex-
press neurofascin on their surface was examined. Since
neurofascin is generated in several isoforms by alternative
splicing (Hassel et al., 1997) in the initial screen for novel
binding partners, a neurofascin isoform (NF22, see Fig. 2
 
D
 
) was used for transfection that shows the strongest bind-
ing activity to NrCAM beads (Volkmer et al., 1996). While
incubation of microspheres coated with TN-C, NgCAM or
NCAM did not lead to detectable binding to neurofascin-
expressing COS7 cells (data not shown), beads conjugated
with F11 (Fig. 1, 
 
A
 
, 
 
D
 
, and 
 
G
 
), axonin-1 (Fig. 1, 
 
B
 
, 
 
E
 
, and
 
H
 
), or TN-R (Fig. 1, 
 
C
 
, 
 
F
 
, and 
 
I
 
) were found to bind to
neurofascin-expressing COS7 cells. Binding to untrans-
fected cells within the same culture or to mock-transfected
cells was not observed (data not shown). To provide addi-
tional data on the specificity, microspheres were incubated
with transfected COS7 cells in the presence of Fab frag-
ments of polyclonal antibodies to the proteins under inves-
tigation. While anti-neurofascin antibodies blocked bind-
ing of F11-, axonin-1–, or TN-R–coated microspheres to
neurofascin-expressing COS7 cells (Fig. 1, 
 
D
 
–
 
F
 
), Fab frag-
ments to F11, axonin-1, or TN-R specifically blocked the
interaction between neurofascin and the respective pro-
tein (Fig. 1, 
 
G
 
–
 
I
 
). Incubating F11-coated beads with COS7
cells expressing neurofascin deletion mutants reveals that
F11 specifically interacts with the Ig-like domains (Fig. 1
 
M
 
), but not with the FNIII-like repeats of neurofascin
(Fig. 1 
 
L
 
). TN-R or axonin-1–coated beads did not bind to
either deletion mutant, suggesting that binding of these
proteins to neurofascin is more complex, and that both
proteins most likely require an intact neurofascin polypep-
tide to bind (data not shown).
To provide further independent evidence on these mo-
lecular interactions of neurofascin, and to study direct
complex formation of neurofascin with F11, and of neuro-
fascin with axonin-1 in neural tissues, neurofascin was im-
munoprecipitated from detergent extracts of embryonic
day 11/12 chick retinae using an mAb to neurofascin. Im-
munoprecipitates were then analyzed in Western blots
using mAbs to different axonal IgSF members. While
NgCAM or NCAM were found not to coprecipitate with
neurofascin, the F11 polypeptide and axonin-1 are clearly
detectable in these blots, suggesting a direct interaction
within the tissue (Fig. 1 
 
N
 
). The same result was obtained
in the reverse experiment when antibodies were used to
precipitate F11 or axonin-1, followed by an analysis of
these precipitates in Western blots with antibodies to neu-
rofascin (data not shown). A coprecipitation analysis of
TN-R could not be performed since the solubilization of
TN-R requires use of urea in the extraction buffer
(Rathjen et al., 1991), which most likely destroys the con-
formation and therefore dissociates these protein com-
plexes (data not shown). 
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In summary, the data obtained demonstrate that in addi-
tion to NrCAM (Volkmer et al., 1996) the GPI-anchored
IgSF members F11 and axonin-1 and the ECM glycopro-
tein TN-R are novel binding partners of neurofascin if
neurofascin is expressed on the cell surface.
 
Differential Binding of TN-R, Axonin-1, and F11 to 
Isoforms of Neurofascin
 
Different neurofascin isoforms are generated by alterna-
tive splicing during embryonic development and, as shown
previously, different combinations of alternatively spliced
stretches of neurofascin modulate the binding to NrCAM
to some extent (Hassel et al., 1997; Volkmer et al., 1996).
To analyze whether distinct neurofascin isoforms bind dif-
ferentially to TN-R, to axonin-1, or to F11, 15 selected
neurofascin isoforms were expressed in COS7 cells (Fig. 2
 
D
 
), and binding of microspheres was quantified and nor-
malized with respect to neurofascin expression on the cell
surface using a confocal microscope as described previ-
ously (Volkmer et al., 1996). In contrast to F11, which
bound to all tested neurofascin isoforms with different ef-
ficiency (Fig. 2
 
 A
 
), significant TN-R binding was only ob-
served to neurofascin isoforms NF15, NF24, NF22, NF34,
NF36, NF38, and NF35 (Fig. 2 
 
B
 
). Removing the NH
 
2
 
-ter-
minal miniexon and/or the miniexon between the Ig- and
FNIII-like repeats resulted in a considerable reduction of
TN-R binding, while inclusion of the PAT domain in-
creased TN-R binding. Furthermore, addition of the
miniexon between the second and third Ig-like domain
slightly decreased binding in several isoforms (NF35 vs.
NF36 or NF38 vs. NF37).
Similar to TN-R binding, a crucial influence of the alter-
natively spliced short stretches and of the PAT domain of
neurofascin was observed on axonin-1 binding. For exam-
ple, removing the miniexon at the junction between the
Ig-like and FNIII-like repeats (NF15 vs. NF17) strongly
reduced axonin-1 binding; however, binding could be re-
stored if the third FNIII-like repeat was replaced by the
PAT domain (NF17 vs. NF22).
Taken together, these binding data on neurofascin iso-
forms indicate that alternative splicing of the neurofascin
gene may be one mechanism to modulate the preference
of neurofascin for one of its ligands, and emphasizes a piv-
otal role of the miniexons within the NH
 
2
 
-terminal half as
well as the PAT domain of neurofascin in the regulation of
binding. In comparison to F11, interactions of neurofascin
with axonin-1 or TN-R are more strongly regulated by
these alternatively spliced stretches.
 
TN-R Induces a Shift in Receptor Usage of
Tectal Cells to Adhere and Extend Neurites on a
Neurofascin/TN-R Complex
 
In addition to alternative splicing, the activities of neuro-
fascin may be regulated by the presence of specific binding
proteins. Therefore, to analyze the function of the interac-
tion between neurofascin and axonin-1, between neurofas-
cin and F11, and between neurofascin and TN-R, we used
in vitro neurite outgrowth and cell attachment assays in
which tectal cells were cultivated on neurofascin-Fc immo-
bilized on culture dishes in the presence of blocking anti-
bodies or of purified soluble proteins. Antibodies to F11,
axonin-1, or TN-R were not found to affect neurite exten-
sion on immobilized neurofascin-Fc, which is known to be
mediated by neuritic NrCAM (see Fig. 4 
 
B;
 
 Volkmer et al.,
1996), suggesting that F11, axonin-1, or TN-R are not im-
portant for neurite extension in this experimental system.
We therefore incubated tectal cells on immobilized neuro-
Figure 1. (A–I) Binding of TN-R, axonin-1, and F11 by neurofas-
cin isoform NF22 expressed on the surface of transfected COS7
cells. Double fluorescence images obtained using a confocal mi-
croscope are shown. The right half of each micrograph of A–I re-
veals neurofascin expression (NF expr.) by indirect immunofluo-
rescence in the FITC channel, while the left half depicts the
binding of F11- (A, D, and G), of axonin-1–(B, E, and H) or of
TN-R– (C, F, and I) conjugated microspheres in the same micro-
scopic field as detected in the Texas Red channel. Each micro-
scopic field also contains unstained cells that do not express neu-
rofascin, and concomitantly do not bind beads. Beads were
incubated in the absence (A–C) or presence of Fab fragments of
polyclonal antibodies to neurofascin (D–F), to F11 (G), to axo-
nin-1 (H), or to TN-R (I), which is indicated at the left of each
panel. (A)Bar, 100 mm. (K–M) F11-coated beads bind to the Ig-
like domains of neurofascin. COS7 cells transfected with plasmid
NF17 (K) expressing both Ig- and FNIII-like domains of neuro-
fascin, deletion mutant NF21 lacking the Ig-like domains (L), or
deletion mutant NF13 lacking the FNIII-like repeats (M) were in-
cubated with F11-coated beads. (K) Bar, 100 mm. NF17 and the
deletion constructs NF21 and NF13 are shown schematically at
the right of each panel. (N) Neurofascin and F11 or neurofascin
and axonin-1 coprecipitate in immunocomplexes. Retinae from
embryonic day 11/12 were solubilized in detergent containing
buffer, and were subjected to immunoprecipitation using an mAb
to neurofascin. Immunocomplexes were separated by SDS-
PAGE and transferred to nitrocellulose, followed by staining
with antibodies to neurofascin (lane 1), F11 (lane 2), axonin-1
(lane 3), NCAM (lane 4), or NgCAM (lane 5). Binding of anti-
bodies was visualized by alkaline-conjugated secondary antibody.
The arrow indicates the heavy chain of the mAb used to immuno-
precipitate neurofascin. 
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fascin-Fc in the presence or absence of soluble F11, axo-
nin-1, or TN-R to study their influence on neurite out-
growth and long-term cell attachment. A neurofascin
isoform was chosen that binds to TN-R and to the other
ligands, and is composed of the extracellular region of
NF15 fused to the Fc portion of human IgG
 
1
 
. It therefore
contains the short exons at the NH
 
2
 
 terminus, and between
the Ig- and FNIII-like domains; however, it lacks the PAT
segment of neurofascin (see Fig. 2 
 
D
 
 for a schematic repre-
sentation of NF15). Among the different combinations
that we analyzed in these assays, the interaction between
neurofascin and TN-R appeared to be of particular impor-
tance since it was found to modulate the behavior of tectal
cells to neurofascin as described below.
In contrast to axonin-1 or F11, application of soluble
TN-R to the immobilized neurofascin-Fc protein resulted
in considerable stimulation of neural long-term cell attach-
ment (Fig. 3, 
 
A
 
 and 
 
B
 
), whereas analysis of the length dis-
tribution of neurites performed in the presence of soluble
TN-R remained unchanged (Fig. 4 
 
E
 
; see below). In-
creased neural attachment was also observed after prein-
cubating the neurofascin-Fc substrate with TN-R, fol-
lowed by removal of unbound TN-R by washing before
adding tectal cells, whereas immobilized TN-R alone does
not allow long-term cell attachment (Fig. 3 
 
A
 
) and neurite
extension of tectal cells of embryonic day 6 (Fig. 4 
 
E
 
;
Rathjen et al., 1991; Nörenberg et al., 1995). Attachment
of tectal cells to the neurofascin-Fc/TN-R complex could
be blocked by polyclonal antibodies to TN-R to levels us-
ing neurofascin-Fc alone, while antibodies to neurofascin
inhibited attachment completely (Fig. 3 A). TN-R did not
enhance neural attachment on the Fc portion without neu-
rofascin sequences, collagen, or F11 substrates (Fig. 3 A).
Application of soluble TN-C, which does not bind to a
neurofascin substrate, did not result in an enhancement of
cell attachment (data not shown), emphasizing the speci-
ficity of the interaction between neurofascin and TN-R
(see Fig. 6 B). These findings indicate that the increase of
attached cells was due to the presence of TN-R and to an
interaction between soluble TN-R with immobilized neu-
rofascin-Fc.
In accordance with previous results, anti-NrCAM anti-
bodies completely abolished cell attachment and neurite
outgrowth on a pure neurofascin-Fc substrate (Fig. 4 B;
Volkmer et al., 1996). In the presence of soluble TN-R,
however, cell attachment (Fig. 3 C) as well as neurite out-
growth (Fig. 4 D) on neurofascin-Fc remained unaffected
by Fab fragments of polyclonal antibodies to NrCAM,
suggesting that NrCAM does not function as a cellular re-
Figure 2. Binding of F11-, axonin-1–, or TN-R–conjugated mi-
crospheres to different isoforms of neurofascin. After transfec-
tion of neurofascin plasmids into COS7 cells and incubation with
fluorescent beads coated with F11 (A), TN-R (B), or axonin-1
(C), the binding of beads on individual cells was quantified and
normalized with respect to the expression level of neurofascin as
described in Materials and Methods. Bars indicate SEM. (D)
Overview of neurofascin isoforms encoded by individual plas-
mids to transfect COS7 cells. Alternatively expressed segments
are hatched. Ig-like domains are indicated by loops, while FNIII-
like repeats are shown as rectangles. All identified neurofascin
sequences (Hassel et al., 1997) are summarized at the left as NF
and isoforms tested in the assay are indicated by NF and a num-
ber. The left schematic version containing all spliced segments
has not been detected in brain tissue (Hassel et al., 1997).The Journal of Cell Biology, Volume 142, 1998 1088
ceptor for cell attachment and neurite extension on the
neurofascin-Fc/TN-R complex, in contrast to the pure
neurofascin-Fc substrate. Fab fragments of polyclonal an-
tibodies to NgCAM had a slight effect, whereas Fab frag-
ments to F11 and axonin-1 both interfered strongly with
cell attachment (Fig. 3 C). Neurite extension was partially
Figure 3. (A–C) The adherence of tectal cells to a neurofascin-Fc
substrate is enhanced in the presence of TN-R. Neurofascin fu-
sion protein with the Fc portion of human IgG1 (FcNF15), the Fc
portion without neurofascin sequences (Fc), F11, BSA, or col-
lagen were immobilized on petriperm dishes, and dissociated tec-
tal cells were incubated in the presence or absence of TN-R (A
and C) or in the presence of F11 or axonin-1 (B). The immobi-
lized proteins, the protein in solution, or the applied antibody is
given at the left of each panel. (A) 10 mg/ml or (C) 50 mg/ml of
TN-R was used to monitor the effects of the different antibodies.
The concentration of soluble F11 or axonin-1 was 20 mg/ml in B.
Long-term attachment (after 22 h) of cells was quantified with
the GENIAS imaging software, and the adherence of tectal cells
to neurofascin (FcNF15) was calculated to 1. Error bars indicate
SEM. TN-R was either provided in the supernatant of a neurofas-
cin substrate during the whole culture period (FcNF15 1 TN-R)
or washed out after a 1 h incubation period before adding the
cells (FcNF15 1 TN-Rprec). Cells were also incubated in the
presence of Fab fragments of polyclonal antibodies specific for
neurofascin (antiNF), NrCAM (antiNr), F11 (antiF11), NgCAM
(antiNg), axonin-1 (antiAx-1), or TN-R (antiTN-R) at a concen-
tration of 100 mg/ml.
Figure 4. Receptor switch from NrCAM to axonin-1 in the pres-
ence of TN-R. (A–D) Representive micrographs of cultures of
tectal cells on a neurofascin-Fc substrate in the absence (A and
B) or in the presence of TN-R (C and D). Anti-NrCAM antibod-
ies block neurite outgrowth on a neurofascin substrate in the ab-
sence (B) but not in the presence of TN-R (D). Bar, 100 mm. (E)
Quantification of neurite extension on neurofascin-Fc (FcNF15)
in the presence or absence of TN-R, and Fab fragments of poly-
clonal antibodies to F11, axonin-1, or NgCAM. The broken line
indicates that tectal cells do not extend neurites on immobilized
TN-R. The lengths of individual neurites were measured with the
GENIAS imaging software, and are plotted as introduced by
Chang et al. (1987). The percentage of neurons (vertical axes)
with neurites longer than or equal to 20 mm (horizontal axis) is
shown. For each experimental condition, 80–120 neurites were
measured. Neurite length of tectal cells is not affected in the pres-
ence of TN-R. Only Fab fragments of polyclonal antibodies to ax-
onin-1 and not to NgCAM or F11 reduce neurite length on a
combined neurofascin/TN-R substrate (P values of the t test:
TN-R vs. TN-R1anti-F11, 0.98; TN-R vs. TN-R1anti-NgCAM,
0.81; TN-R vs. TN-R1anti-Ax-1; 0.0002).Volkmer et al. Molecular Interactions of Neurofascin 1089
inhibited by Fab fragments to axonin-1, while antibodies
to NgCAM or F11 did not inhibit neurite outgrowth (Fig. 4
E) on the neurofascin-Fc/TN-R complex. These observa-
tions suggest that under these experimental conditions,
F11, axonin-1, and probably an unknown component
(however not NrCAM) are important for the attachment
of neural cells to the neurofascin-Fc/TN-R complex, while
neurite extension appears to be dependent on axonin-1
and at least one unknown surface protein. In comparison
to a pure neurofascin substratum, formation of a neurofas-
cin/TN-R complex therefore results in a shift of receptor
usage of tectal cells to adhere and extend neurites.
Competition Among F11, Axonin-1, NrCAM, and
TN-R to Bind to Neurofascin
One explanation for the finding that NrCAM is replaced
as receptor for cell adhesion and neurite extension on the
neurofascin-Fc/TN-R complex might be that TN-R steri-
cally blocks the NrCAM binding region within neurofas-
cin, but still allows binding of axonin-1 and F11 expressed
by tectal cells to neurofascin or to the neurofascin/TN-R
complex. To mediate the attachment of tectal cells, axo-
nin-1 may directly interact with neurofascin and not with
TN-R of the complex since no direct binding between axo-
nin-1 and TN-R has been detected so far in different bind-
ing assays (Nörenberg et al., 1995 and data not shown).
F11 may either bind to TN-R as shown in a previous com-
munication (Brümmendorf et al., 1993; Rathjen et al.,
1991; Nörenberg et al., 1995) or to neurofascin as shown
above. To address these questions we made use of the ob-
servation that some neurofascin isoforms bind TN-R, and
others do not. COS7 cells were transfected with the TN-
R–binding isoform NF22 and the nonbinding isoform
NF17 (see Fig. 2 B), followed by an incubation with F11-,
axonin-1-, or NrCAM-coated microspheres in the pres-
ence or absence of soluble TN-R or of soluble TN-C as a
control (Fig. 5).
Incubation of NrCAM-coated beads with NF22-express-
ing COS7 cells led to a significant reduction of NrCAM
bead binding in the presence of TN-R (Fig. 5 B). In accor-
dance, NrCAM bead binding to TN-R nonbinder NF17
(Fig. 5 A) remained unaffected, indicating that binding of
TN-R to neurofascin is required for the competition of the
neurofascin–NrCAM interaction, and that NrCAM does
not bind to the neurofascin–TN-R-complex (Fig. 5 B). TN-C
instead of TN-R that binds neither NrCAM nor neurofas-
cin did not compete NrCAM bead binding, indicating fur-
ther specificity (Fig. 5, A and B). Binding of F11-coated
beads to NF17 is markedly reduced in the presence of solu-
ble TN-R or TN-C (both are known to bind F11 [Zisch et al.,
1992; Nörenberg et al., 1995]), indicating that both com-
pete with neurofascin for the binding site on F11 (Fig. 5 D).
In contrast, if the TN-R–binding neurofascin isoform
NF22 was expressed, F11 bead binding to neurofascin-
expressing cells remained unaffected in the presence of solu-
ble TN-R, but not TN-C (Fig. 5 E). Binding of axonin-1–
coated beads to NF22 (TN-R binder) was completely blocked
by soluble TN-R (Fig. 5 C). Competition binding experi-
ments using NF17 and axonin-1–conjugated beads could
not be performed due to its low binding activity to axonin-1.
In summary, these binding assays indicate that TN-R in-
terferes with neurofascin-NrCAM and neurofascin–axo-
nin-1 interactions if an isoform of neurofascin is tested
that is able to bind to TN-R. Furthermore, axonin-1 does
not bind to the neurofascin/TN-R complex while F11
binds to oligomeric TN-R (Nörenberg et al., 1995) within
the neurofascin/TN-R complex. In the latter case, oligo-
meric TN-R might link F11-conjugated beads to neurofas-
cin-expressing COS7 cells by generating a bridge. In con-
trast, in the case of a neurofascin TN-R nonbinder, a
decreased neurofascin–F11 interaction is observed. Cell
attachment to neurofascin/TN-R complex mediated by
F11 might therefore include binding of F11 expressed on
tectal cells to TN-R while axonin-1–mediated cell attach-
ment and neurite outgrowth does not include binding of
axonin-1 to neurofascin/TN-R. This interpretation sug-
gests an involvement of an additional cell surface receptor
for TN-R for neurite extension on the neurofascin–TN-R
complex.
Analysis of the Neurofascin-TN-R Binding by
Domain-specific Antibodies to TN-R
Since the neurofascin–TN-R interaction appeared to be of
particular interest, and since cell attachment and neurite
extension is only partially blocked by antibodies to F11 or
axonin-1, we further analyzed binding of TN-R to neuro-
fascin and cell attachment to the neurofascin–TN-R com-
plex. Also, to address the question whether additional cel-
Figure 5. Soluble TN-R and TN-C differentially compete for
ligand binding to neurofascin. Microspheres coated with NrCAM
(A and B), axonin-1 (C), or F11 (D and E; indicated on the top of
the panel) are incubated with COS7 cells expressing neurofascin
variants NF17 or NF22 (see bottom row). Competitor indicates
TN-R or TN-C in solution at a concentraion of 150 mg/ml. The in-
terpretation of the results is illustrated schematically in the lower
half of the figure. Circles indicate fluorescent beads conjugated
with NrCAM, axonin-1, or F11. NF22 is shown as a filled and
NF17 as a hatched ellipse. The indication that F11 binds to TN-R
while NrCAM and axonin-1 do not is based on previous studies
(Nörenberg et al., 1995). Bars on the columns indicate SEM.The Journal of Cell Biology, Volume 142, 1998 1090
lular receptors beside F11 and axonin-1 interact with the
neurofascin-Fc–TN-R complex, we used domain-specific
antibodies to TN-R to discriminate between the binding
sites of neurofascin, F11, and a putative unknown cellular
receptor within TN-R. The F11-binding site on TN-R has
been previously mapped to FNIII-like repeats 2–3 of TN-R
(Nörenberg et al., 1995). For allocation of neurofascin-
binding sites within TN-R, microspheres coated with TN-R
were incubated with neurofascin-expressing COS cells in
the presence of Fab fragments of domain-specific poly-
clonal antibodies raised against fusion proteins of individ-
ual TN-R domains (Fig. 6 A). Only Fab fragments directed
to domains 2–3FNIII or 4-AFNIII blocked the neurofascin–
TN-R interaction. All other domain-specific Fab frag-
ments, including Fab fragments to FNIII-like repeat A,
did not reduce the binding of TN-R microspheres, indicat-
ing that TN-R FNIII-like repeats 2–5 are important for
neurofascin binding, and that neurofascin and F11-binding
sites within TN-R are overlapping. However, the neuro-
fascin-binding region within TN-R appears to be larger
than the F11-binding region.
Domain-specific Fab fragments of polyclonal antibodies
to TN-R were used to interfere with neural attachment to
the neurofascin–Fc/TN-R complex (Fig. 6 B). While Fab
fragments specific for the EGF-like domains and FNIII-
like repeat 1 had no effect on neural cell attachment, Fab
fragments covering FNIII-like repeats 2-A significantly
blocked neural cell attachment. This observation might be
explained by the findings that TN-R binds to neurofascin
via its FNIII-like domains 2–5, and that the presence of
these antibodies do not allow formation of the neurofas-
cin–TN-R complex (Fig. 6 A). Antibodies directed to all
other more COOH-proximal domains of TN-R also re-
duced tectal cell attachment significantly. The findings ob-
tained with domain-specific polyclonal antibodies are in
line with results aquired with mAbs to TN-R. Long-term
cell attachment of tectal cells was reduced to control levels
by anti-TN-R mAb 23–14 that binds to FNIII-like module
8, but not by mAb 23–13, whose epitope was mapped to
FNIII-like repeat 1 of TN-R. mAb 23–14 has been also
shown to interfere with short-term attachment of retinal
cells mediated by a so far unknown cellular receptor
(Nörenberg et al., 1995). The comparison of the regions
within TN-R required to bind to neurofascin with those
that are implicated in cell attachment to neurofascin-Fc–
TN-R suggest that in addition to F11 and axonin-1 in-
teractions mediated by other so far unknown cellular
components might play a role on the combined neurofas-
cin–TN-R complex.
Discussion
We have defined TN-R, F11, and axonin-1 as new binding
partners of neurofascin by using a cellular binding assay
previously found to be reliable for detecting interactions
of axonal IgSF members (Rader et al., 1996; Morales et al.,
1993; Brümmendorf et al., 1993). As found for other mem-
bers of the L1 subfamily of the IgSF (Brümmendorf et al.,
1998), neurofascin shows a relatively broad binding activ-
ity. Since the ligands of neurofascin, F11, axonin-1, TN-R,
and NrCAM itself also reveal a complex binding behavior
Figure 6. Neurofascin–TN-R interaction in the presence of do-
main-specific antibodies to TN-R. (A) Micrographs of neurofas-
cin NF22–expressing COS7 cells incubated with TN-R–coated
beads in the presence of Fab fragment of polyclonal antibodies
(concentration 200 mg/ml) specific for individual TN-R domains
is shown. Only Fab fragments to FNIII-like repeats 2-3 and 4-A
block TN-R bead binding. Neurofascin expression is shown in the
left columns, while TN-R binding is revealed in the right col-
umns. Fab fragments of polyclonal antibodies to invidual do-
mains to TN-R applied are indicated at the left and right of the
panel. (B) Quantification of cell attachment of tectal cells to the
combined neurofascin-Fc/TN-R substrate in the presence of Fab
fragments of polyclonal antibodies to individual domains of TN-R
or in the presence of mAb 23–13 or mAb 23–14 directed to
TN-R. Bars on the columns indicate SEM. (C) Scheme of the
TN-R polypeptide. Alternative spliced segments are indicated in
black. FNIII-like repeats are indicated as rectangles, and are
numbered. EGF-like domains are depicted as small circles, and
the fibrinogen-like segment as large circle. (D) Comparison of
the inhibition of TN-R binding to neurofascin, and of the inhibi-
tion of cell attachment of tectal cells to the neurofascin/TN-R
complex.Volkmer et al. Molecular Interactions of Neurofascin 1091
(Pesheva et al., 1993; Friedlander et al., 1994; Peles et al.,
1995; Sakurai et al., 1997; Peles et al., 1997; Kunz et al.,
1996; Rader et al., 1996; Suter et al., 1995; Buchstaller et
al., 1996; Kuhn et al., 1991; Morales et al., 1993; Brümmen-
dorf et al., 1993; Schumacher et al., 1997; Nörenberg et al.,
1995), it appears that neurofascin is a component of a com-
plex network of molecular interactions, and that it proba-
bly acts in the form of complexes in the developing ner-
vous system to regulate axonal growth. This view is also
supported by the partial overlapping distribution of these
proteins in several vertebrate fiber tracts, including the vi-
sual system (Brümmendorf and Rathjen, 1995). Although
the membrane topology of the neurofascin interactions
has not been investigated in this study, neurofascin might
also recruit F11 or axonin-1 within the same plasma mem-
brane to form receptor complexes, as it has been found for
NgCAM that cooperates with axonin-1 on DRG neurons
to extend neurites, or with F11 (Stoeckli et al., 1996;
Kunz et al., 1996; Brümmendorf et al., 1993; Buchstaller et
al., 1996). Similarly, NrCAM forms complexes with F11
(Sakurai et al., 1997; Morales et al., 1993), which is impli-
cated in neurite outgrowth induced by the receptor ty-
rosine phosphatase b/z (Peles et al., 1995).
To gain further insight into the function of the individ-
ual isoforms of neurofascin, we have analyzed 15 distinct
isoforms to bind to TN-R, axonin-1, and F11. These stud-
ies show that the different isoforms of neurofascin reveal a
differential binding to TN-R and axonin-1, indicating that
one function of the extensive alternative splicing of the
neurofascin gene is to modulate ligand recognition. The
interaction of F11 with different neurofascin isoforms
roughly resembles the binding behavior of NrCAM to
neurofascin, which has been detailed in a previous com-
munication (Volkmer et al., 1996). The Ig-like domains of
neurofascin are sufficient to bind both proteins. In con-
trast, TN-R and axonin-1 binding requires additional re-
gions, and is regulated more tightly by alternative splicing,
which is also reflected by the observation that certain iso-
forms do not display any binding to TN-R–coated micro-
spheres. The generation of different isoforms might there-
fore provide a fine tuning of the binding activities of
neurofascin. Several investigations have addressed the
function of alternative splicing in extracellular regions of
other IgSF members. For example, an alternatively spliced
exon termed VASE introduces 10 additional amino acid
residues within the fourth Ig-like domain (Small and Ake-
son, 1990; Small et al., 1988; Santoni et al., 1989), resulting
in a modulation of neurite outgrowth promotion (Liu et
al., 1993; Doherty et al., 1992) and the signaling activity of
NCAM (Saffell et al., 1997; Brittis et al., 1996). In the FGF
receptor 1, the alternate usage of two exons encoding two
different COOH-terminal halves of the third Ig-like do-
main modulate the affinity for one of its ligands, bFGF
(Werner et al., 1992). Furthermore, alternatively spliced
exons coding for the Ig-like domains of vascular cell adhe-
sion molecule-1 generate either one or two binding sites
for an integrin receptor, resulting in different adhesive
properties of these isoforms (Vonderheide and Springer,
1992). The interaction between neurofascin and axonin-1,
and between neurofascin and TN-R is enhanced either by
introduction of the PAT domain or by the short stretches
at the NH2 terminus, and between the Ig-like and the
FNIII-like domains. These elements may modulate the
flexibility of the neurofascin polypeptide either by provid-
ing an extended O-glycosylated segment in the case of the
PAT domain, or a hinge-like structure. As these alterna-
tively spliced segments within neurofascin can comple-
ment each other with respect to the enhancement of bind-
ing to axonin-1 or TN-R, there appear to be independent
regions in the extracellular part of neurofascin that affect
binding. Interestingly, expression of the exons that encode
these stretches are developmentally regulated. While ex-
ons 3 and 17 (segments at the NH2 terminus and between
the Ig- and FNIII-like regions, respectively) are found
early in development, exon 27 (PAT domain) appears late
in the development of the chicken brain (Volkmer et al.,
1992; Hassel et al., 1997). The 17 amino acid residue–long
segment between Ig-like domains two and three that is ex-
pressed late in development and that slightly abolishes
binding to axonin-1 or TN-R in several neurofascin iso-
forms might increase the distance between these neighbor-
ing domains, and therefore might decouple intrachain
interactions. This interpretation is supported by a key resi-
due analysis of the related human L1, indicating that Ig-
like domains two and three are linked by amino acid re-
sidues that are not involved in b-sheet formation of the
preceding or following Ig-like domain (Bateman et al.,
1996). This structural feature may influence the orienta-
tion of neighboring domain faces, and can also be ex-
pected to be shared by neurofascin due to its relationship
to L1. The modulation of binding might also affect the lo-
calization of neurofascin isoforms into specialized struc-
tures. For example, a neurofascin form that contains the
fifth FNIII-like repeat is localized at the nodes of Ranvier,
whereas an isoform encompassing the FNIII-like domains
1–4 was found on unmyelinated axons (Davis et al., 1996).
Our previous investigations have shown that neurite ex-
tension of tectal cells mediated by a pure neurofascin sub-
stratum requires NrCAM on the axonal surface (Volkmer
et al., 1996). In the present study neurite outgrowth and
cell attachment assays in the presence of specific antibod-
ies show that the usage of NrCAM as a cellular receptor
for substrate-bound neurofascin is replaced if TN-R is
bound to neurofascin. Instead, F11, axonin-1, and at least
one additional cellular receptor are involved in axon ex-
tension and cell attachment on the combined neurofascin–
TN-R substrate. Such a shift in receptor usage might be
important within the retina, where neurofascin and TN-R
colocalize in the inner and outer plexiform layer, but not
in the optic fiber layer at specific developmental stages
(Rathjen et al., 1991; Volkmer et al., 1996). It is therefore
conceivable that neurofascin–NrCAM interactions are of
importance on ganglion cell axons in the optic fiber layer,
while the presence of TN-R reduces a neurofascin–
NrCAM interaction on the neurites of the interneurons in
the plexiform layers of the retina. One explanation that
NrCAM is replaced as a receptor might be that TN-R ster-
ically blocks the NrCAM-binding region within neurofas-
cin. Previous investigations have shown that F11 binds di-
rectly to TN-R, while axonin-1 and NrCAM are not able
to bind to TN-R (Brümmendorf et al., 1993; Pesheva et al.,
1993; Xiao et al., 1996; Nörenberg et al., 1995). Our com-
petition-binding experiments also suggest an interaction of
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but not with neurofascin itself. First, TN-R strongly com-
petes with neurofascin (NF17) to bind F11, making it un-
likely that F11 directly binds to neurofascin in the presence
of TN-R. Second, although Fab fragments of polyclonal
antibodies to F11 block adherence to the combined neuro-
fascin–TN-R substrate, they neither affect cell attachment
nor neurite outgrowth on the pure neurofascin substrate,
indicating that in the absence of TN-R a putative neuro-
fascin–F11 interaction has no functional consequences
in this experimental system (Volkmer et al., 1996). Third,
the competition binding assays further suggest an indepen-
dent binding of F11 and neurofascin (NF22) to TN-R, as
F11-coated microspheres may be linked to neurofascin
(NF22)-expressing COS cells by a TN-R bridge. Mapping
studies indicate that F11 binds to the FNIII-like repeats
2–3 of TN-R (Nörenberg et al., 1995), while neurofascin
presumably binds to a broader overlapping region.
In contrast, axonin-1, which is implicated in neurite ex-
tension and cell attachment on the neurofascin–TN-R
complex on the basis of the antibody perturbation experi-
ments (Figs. 3 and 4), does not directly bind to the neuro-
fascin–TN-R complex as it has been shown by the compe-
tition-binding assay (Fig. 5). Therefore, axonin-1 may
interact with other cellular surface proteins within the
same plasma membrane to mediate neurite outgrowth on
the neurofascin–TN-R complex. For example, the ho-
mophilic interaction between a substrate of purified Ng-
CAM and cellular NgCAM has been shown to require a
cis interaction of cellular axonin-1 with NgCAM within
the same plasma membrane of DRG neurons (Buchstaller
et al., 1996; Kuhn et al., 1991). The participation of
NgCAM in a cis complex with axonin-1 can be excluded
on the combined neurofascin–TN-R substrate since poly-
clonal antibodies directed to NgCAM did not interfere
with neurite outgrowth or cell attachment (see Fig. 4). On
the basis of the experiments using domain-specific anti-
bodies to TN-R, it is conceivable that additional so far un-
known receptor protein(s) on tectal cells in association with
axonin-1 and/or F11 probably interact with the FNIII-like
domains 6–8 and the fibrinogen segment within TN-R.
In conclusion, this and our previous study suggest that
neuronal cells are able to regulate the molecular activities
of the L1-like protein neurofascin at different levels. First,
the neurofascin–NrCAM interaction is not reciprocal, in
contrast with the F11–NrCAM interaction (Volkmer et al.,
1996). Second, the presence or absence of specific interact-
ing proteins such as TN-R in the local environment of an
extending axon might be a possibility to influence receptor
usage as shown for the neurofascin–NrCAM interaction.
Alternative splicing of the pre-mRNA might be a third
possibility in that it modulates the preferences for specific
ligands (e.g., TN-R binder or TN-R nonbinder). Regula-
tion of the binding activities would greatly expand the
number of guidance cues provided by neurofascin in the
developing brain.
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